| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/19/2001 | EP1133479A1 Quinoline and quinoxaline compounds |
| 09/19/2001 | EP1133478A1 Novel acylguanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them |
| 09/19/2001 | EP1133477A1 Substituted benzimidazoles and their use as parp inhibitors |
| 09/19/2001 | EP1133476A1 Iminoguanidine derivatives, preparation method, use as medicines |
| 09/19/2001 | EP1133471A1 Hydrazine derivatives |
| 09/19/2001 | EP1133317A1 Transport system conjugate |
| 09/19/2001 | EP1133311A2 INFLUENCING OF ANGIGENESIS USING CD66a |
| 09/19/2001 | EP1133310A2 Artery- and vein-specific proteins and uses therefor |
| 09/19/2001 | EP1133303A2 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 09/19/2001 | EP1133280A1 Method of preparing stable suspensions of insoluble microparticles |
| 09/19/2001 | EP0948522A4 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
| 09/19/2001 | EP0923529B1 Substitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 09/19/2001 | EP0862634B1 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 09/19/2001 | EP0853616B1 Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| 09/19/2001 | EP0600062B1 Polymer-bound paclitaxel derivatives |
| 09/19/2001 | EP0594667B1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 09/19/2001 | EP0593755B1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment |
| 09/19/2001 | CN1313897A New gene of humanlysoenzyme, the encoding polypeptide and methods for preparing them |
| 09/19/2001 | CN1313863A Inhibitors of urokinase and blood vessel fomation |
| 09/19/2001 | CN1313855A Inhibitors of alpha4Betal mediated cell adhesion alpha Beta |
| 09/19/2001 | CN1313775A Methods and materials for the treatment of prostatic cercinoma |
| 09/19/2001 | CN1313774A Vaccine comprising cytokine-induced heat shock proteins |
| 09/19/2001 | CN1313773A Antigenic peptides derived from telomerase |
| 09/19/2001 | CN1313772A Peptide antagonists of zonulin and methods for use of same |
| 09/19/2001 | CN1313766A DNA-cleaving antitumor agents |
| 09/19/2001 | CN1313765A Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents |
| 09/19/2001 | CN1313764A New use of taxoid derivatives |
| 09/19/2001 | CN1313388A Polypeptide-short-chain dehydrogenase/reducatase 14 and polynucleotide for coding it |
| 09/19/2001 | CN1313343A N-terminal modified protein compositions and methods therefor |
| 09/19/2001 | CN1313337A Polypeptide-zinc finger protein 10 and polynucleotide for coding it |
| 09/19/2001 | CN1313328A Polypeptide-human primary cadherin 14 and polynucleotide for coding it |
| 09/19/2001 | CN1313325A Polypeptide-human zinc finger protein 15 and polynucleotide for coding it |
| 09/19/2001 | CN1313318A Human protein able to suppress growth of cancer cells and its coding sequence |
| 09/19/2001 | CN1313317A Human protein able to suppress growth of cancer cells and its coding sequence |
| 09/19/2001 | CN1313316A Human protein able to suppress growth of cancer cells and its coding squence |
| 09/19/2001 | CN1313315A Human protein able to suppress growth of cancer cells and its coding sequence |
| 09/19/2001 | CN1313310A Polypeptide-human zinc finger protein 14 and polynucleotide for coding it |
| 09/19/2001 | CN1313308A Polypeptide-human zinc finger protein 17 and polynucleotide for coding it |
| 09/19/2001 | CN1313302A Polypeptide-human zinc finger protein 27 and polynucleotide for coding it |
| 09/19/2001 | CN1313300A Polypeptide-human interleukin conjugon 13 and polynucleotide for coding it |
| 09/19/2001 | CN1313284A N-(3-benzofuryl) urea derivative |
| 09/19/2001 | CN1313130A Application of RIZ gene in detecting and treating tumor showing MSI positive |
| 09/19/2001 | CN1313099A Centipede-snake plaster |
| 09/19/2001 | CN1313098A Shegong powder |
| 09/19/2001 | CN1313093A Detoxicating pill 'Niuhuang Yincui' |
| 09/19/2001 | CN1071336C Compositions by using unbound MPL receptor for stimulating platelet production |
| 09/19/2001 | CN1071329C Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/19/2001 | CN1071318C Ortho-substd. benzoyl guanidines, their preparing process and use as medicine and diagnostic reagent, and medicine contg. same |
| 09/19/2001 | CN1071129C Pill for relief of choke |
| 09/19/2001 | CN1071114C Injectable mesna solutions |
| 09/19/2001 | CA2372450A1 Liquid injectable formulation of disodium pamidronate |
| 09/18/2001 | US6291690 Hydrophobic taxane derivatives |
| 09/18/2001 | US6291679 Process for preparing benzoperhydroisoindole compounds |
| 09/18/2001 | US6291643 Apaf-1 an activator of caspase-3 |
| 09/18/2001 | US6291642 Mammalian cell cycle protein |
| 09/18/2001 | US6291522 Cyclopentane heptan(ENE)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
| 09/18/2001 | US6291516 Contacting the cell with a composition including at least one cyclic amp agonist. |
| 09/18/2001 | US6291505 Pyrazole estrogen receptor agonist and antagonist |
| 09/18/2001 | US6291504 Potent inhibitors of the class of enzymes known as cyclin dependent kinases |
| 09/18/2001 | US6291503 β-phenylalanine derivatives as integrin antagonists |
| 09/18/2001 | US6291484 Treatment of the various medical conditions associated with postmenopausal syndrome |
| 09/18/2001 | US6291459 Calcilytic compounds |
| 09/18/2001 | US6291458 Morpholinobenzamide salts |
| 09/18/2001 | US6291457 Compounds having cytokine inhibitory activity |
| 09/18/2001 | US6291456 Compounds and methods for modulation of estrogen receptors |
| 09/18/2001 | US6291455 Producing an antiangiogenic and/or vascular permeability reducing effect |
| 09/18/2001 | US6291451 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 09/18/2001 | US6291450 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 09/18/2001 | US6291430 Mage-3 peptides presented by HLA class II molecules |
| 09/18/2001 | US6291425 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 09/18/2001 | US6291237 Cancer diagnosis and therapy based on mutations in TGF-β receptors |
| 09/18/2001 | US6290955 Antibodies against T cells as therapeutics |
| 09/18/2001 | US6290953 May be a conjugate which includes a targeting portion adapted to target the conjugate to a specific cell type or anatomical location. |
| 09/18/2001 | US6290951 Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells |
| 09/18/2001 | US6290929 Cancer treatment |
| 09/18/2001 | US6290712 Laser/sensitizer assisted immunotherapy |
| 09/18/2001 | CA2045783C 9-purinyl phosphonic acid derivatives |
| 09/15/2001 | WO2001068859A2 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | WO2001066747A2 Proteins named fctrx and nucleic acids encoding same |
| 09/15/2001 | CA2403370A1 Il-17 receptor like molecules and uses thereof |
| 09/15/2001 | CA2401552A1 Proteins named fctrx and nucleic acids encoding same |
| 09/13/2001 | WO2001066785A1 Phosphatidyl serine receptors and uses thereof |
| 09/13/2001 | WO2001066772A2 Heparinase iii and uses thereof |
| 09/13/2001 | WO2001066753A2 Human genes and gene expression products |
| 09/13/2001 | WO2001066746A2 G-protein coupled receptor related polypeptides |
| 09/13/2001 | WO2001066742A2 G-protein coupled receptors |
| 09/13/2001 | WO2001066741A2 Kcnb: a novel potassium channel protein |
| 09/13/2001 | WO2001066737A1 Polypeptide inducing apoptosis |
| 09/13/2001 | WO2001066716A1 Polypeptide having phosphodiesterase activity |
| 09/13/2001 | WO2001066706A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/13/2001 | WO2001066601A1 Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 09/13/2001 | WO2001066599A1 Crystal |
| 09/13/2001 | WO2001066595A2 Human fgf-23 gene and gene expression products |
| 09/13/2001 | WO2001066594A2 Human protein kinases and protein kinase-like enzymes |
| 09/13/2001 | WO2001066585A1 A new polypeptide-human protease regulatory protein 10 and the p olynucleotide encoding it |
| 09/13/2001 | WO2001066583A1 A new polypeptide - human zinc finger protein 14 and the polynucleotide encoding it |
| 09/13/2001 | WO2001066582A1 A NEW POLYPEPTIDE-HUMAN ZINC FINGER PROTEIN 27 AND THE POLYNUCLEOTIDE ENCODING It |
| 09/13/2001 | WO2001066580A1 A new polypeptide-human zinc finger protein 13 and the polynucleotide encoding it |
| 09/13/2001 | WO2001066579A1 A new polypeptide- human cytochrome constitutive protein 14 and the polynucleotide encoding it |
| 09/13/2001 | WO2001066566A2 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids |